Angiodynamics (ANGO) Non-Current Assets (2011 - 2026)

Angiodynamics' Non-Current Assets history runs 16 years deep, the most recent figure standing at $103.8 million for Q2 2026.

• Quarterly Non-Current Assets fell 7.2% year-over-year to $103.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $426.2 million (down 7.77% YoY) and the FY2026 annual result came in at $103.8 million, down 7.2% from the prior year.
• Non-Current Assets was $103.8 million for Q2 2026 at Angiodynamics, down from $105.1 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $415.5 million in Q1 2022 and bottomed at $103.8 million in Q2 2026.
• A 5-year average of $231.3 million and a median of $126.2 million in 2024 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets declined 2.65% — and 2024, when it tumbled 67.22%.
• Angiodynamics' Non-Current Assets stood at $399.4 million in 2022, then declined by 21.34% to $314.1 million in 2023, then slumped by 63.01% to $116.2 million in 2024, then declined by 6.76% to $108.3 million in 2025, then decreased by 4.21% to $103.8 million in 2026.
• Business Quant data shows ANGO's Non-Current Assets at $103.8 million in Q2 2026, $105.1 million in Q1 2026, and $108.3 million in Q4 2025.